TRANSVAC

LIONEX DIAGNOSTICS AND THERAPEUTICS

TRANSVAC: New Vaccines Faster

TRANSVAC is a collaborative infrastructure project funded by the European Commission (EC), initially under the 7th Framework Programme (FP7) and currently under Horizon 2020.  The project is a joint effort of leading European groups working in the field of vaccine development, and is coordinated by the European Vaccine Initiative (EVI). TRANSVAC is designed to accelerate vaccine development by enhancing European vaccine research and training, and increase sustainability of EC vaccine projects by implementing a permanent research infrastructure for early vaccine development.

LIONEX was a partner in Transvac.

 

If you have any question please contact us

Lionex

© 2018 Lionex GmbH

Last update:  Apr 10, 2020 @ 18:01 Lionex GmbH

TÜV Rheinland